Unconfigured Ad
Collapse
X
-
I read somewhere in one of the other posts on here that after the tagmentation you still need to amplify your DNA using PCR if you haven't already. The amount of DNA after tagmentation is quite a low amount so might not be being detected on the BA. The 10,380bp peak might just be the upper marker of the HS DNA assay.
-
Unable to get ATAC-seq to work
good morning. for the past several days, i have been attempting to perform ATAC-seq on some Jurkat cell pellets. i am following the Buenrostro/Greenleaf protocol published in Current Protocols (2016). to-date, i cannot get the tagmentation reaction to work. i have tried several different conditions; e.g., 1) running a titration experiment using 7.4K, 14.8K, 29.5K, 44.3K, 59K, and 88.5K live cells from a cell pellet assuming 59% live cells; 2) eliminating the lysis step, which i read in one of the threads on this site, using 14.8K, 44.3K, and 59K live cells. each time, i've isolated the nuclei and immediately performed the tagmentation reaction. after cleaning up the reaction, the BA traces show only one large (10,380bp) peak, indicating no fragmentation and hence, no tagging. to test the enzyme, i used commercial DNA. the tagmentation reaction didn't work, so i called Illumina. they suggested running the DNA through a column since some of the commercial gDNA preps contain EDTA to which the transposase is very sensitive. once i cleaned up the gDNA, the fragmentation reaction worked well. i was going to put the isolated nuclei over a clean-up column, but my boss informed me that it would relax most of the supercoiled DNA, resulting in fragmentation of all the gDNA, instead of just the accessible chromatin sites. does anyone have any suggestions that i can try? i have read on this site that many of you are getting very good results using the Greenfield protocol. i welcome any advice you can offer. thanks so much for your time. laura hallTags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
43 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: